DSGN Q3 2025 Earnings — Design Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DSGNDesign Therapeutics, Inc.

$569M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$15M

Operating Income

-$19M

Net Income

-$17M

EPS (Diluted)

$-0.30

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$212M

Total Liabilities

$12M

Stockholders' Equity

$200M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$15M	$0	—
Operating Income	-$19M	-$16M	-18.9%
Net Income	-$17M	-$13M	-30.4%